According to a report, a survey of 346 doctors revealed that 89% of them have seen a recent increase in patients requesting weight-loss medications in 2023.
Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
Bethany Shipsey, 21, died from the toxic effects of Dinitrophenol in February 2017. A coroner had ruled her death as suicide, ...
Dr. Oz, CMS nominee, is facing questions from the Senate today about his past promotion of dubious weight loss supplements, ...
The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company ...
Sirona is a dual-polymer hydrogel pill that expands in the stomach, reducing appetite. Participants consumed 400 fewer ...
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
8don MSN
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback